GlobalData on MSN
Natera, Aveta Biomics collaborate on head and neck cancer trial
Around 826 participants will be recruited across Australia, Asia-Pacific, Europe and North America.
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, and Aveta Biomics, Inc., a ...
I am going to take a deep dive into Biomics Biopharma Limited’s (ASX:BBM) most recent ownership structure, not a frequent subject of discussion among individual investors. Ownership structure has been ...
Farmington, CONN. – General Biomics, Inc. and The Jackson Laboratory (JAX) announced an expansive and exclusive intellectual property licensing agreement across six areas of human health. The ...
HAYWARD, Calif.--(BUSINESS WIRE)--Applied Biomics, Inc., a leading Proteomics service provider, adds a HCP profiling analysis using their well established high resolution, large format 2-Dimensional ...
The BIOMICs Group, based at the Lucio Lascaray building in the Álava/Araba campus of the University of the Basque Country (UPV/EHU), is specially known for overseeing the SGIker DNA Bank, not only ...
SAN MATEO, CALIFORNIA – Maverix Biomics, Inc., a leading genomic analysis software company, today announced the appointment of J. Thomas Kent as Vice President of Research & Development. Mr. Kent has ...
A new medical research center opens in London today (April 1), that will bring together scientists in four key areas to generate novel treatments for diseases such as cancer, heart disease and ...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, and Aveta Biomics, Inc., a clinical-stage immuno-oncology company advancing first-in-class oral immunotherapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results